Omeros Corporation (OMER) vs Oric Pharmaceuticals, Inc. (ORIC)

Omeros Corporation and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Omeros Corporation and Oric Pharmaceuticals, Inc. are of similar size ($1.4B and $1.3B). Oric Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. Omeros Corporation has the higher net margin (128.4% vs 0.00%) and the higher return on invested capital (0.00% vs −83.8%). Across the 13 metrics below, Omeros Corporation leads on 9 and Oric Pharmaceuticals, Inc. on 4.

Valuation

Metric OMER ORIC Biotechnology median
P/E 9.47 n/m 8.50
P/S 12.02 n/m 9.71
P/B n/m 3.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 11.83 n/m 9.21
Earnings yield 10.56% (10.93%) (33.15%)
Free cash flow yield (5.88%) (8.42%) (25.50%)

Profitability

Metric OMER ORIC Biotechnology median
Gross margin 37.57% 0.00% 65.16%
Operating margin (74.88%) 0.00% 0.00%
Net margin 128.36% 0.00% 0.00%
Free cash flow margin (70.69%) 0.00% 0.00%
Return on equity (89.15%) (39.80%) (56.36%)
Return on assets 51.22% (37.35%) (48.04%)
Return on invested capital 0.00% (83.77%) 0.00%

Growth

Metric OMER ORIC Biotechnology median
Revenue growth (TTM) 36.32% — 6.02%
EPS growth (last fiscal year) 98.15% 19.67% 30.26%
Revenue growth, 5-year CAGR 40.44% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OMER ORIC Biotechnology median
Debt to equity (1.89) 0.00 0.00
Current ratio 1.95 13.19 4.72
Net debt to EBITDA (0.30) 1.95 0.96

Dividend

Metric OMER ORIC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric OMER ORIC Biotechnology median
Market cap 1.36b 1.32b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack